Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
IMIGLUCERASE
Cerezyme
Gaucher Disease
CZ-011-01NANCT00364858Tabulated Results
IMIGLUCERASE
Cerezyme
Gaucher Disease Type Ⅲ
LPS16031SEEDEudraCT Number: 2024-000041-27Tabulated Results
IMIGLUCERASE
Cerezyme
Gaucher Disease
RC 91-0110*NASummary
IMIGLUCERASE
Cerezyme
Gaucher Disease
RC 92-0301*NASummary
IMIGLUCERASE
Cerezyme
Gaucher Disease
RC 92-0501*NASummary
IMIGLUCERASE
Cerezyme
Gaucher Disease
RC96-1101*NANCT00365131Summary
INIPARIB
Not Marketed
Peritoneal and Ovarian Cancer
ARD11489NANCT00677079Summary
INIPARIB
Not Marketed
Advanced solid tumors
BEX11505NANCT01161836Summary
INIPARIB
Not Marketed
Breast Cancer
EFC11486NANCT00938652Summary
INIPARIB
Not Marketed
Non-small cell lung cancer
EFC11553NAEudraCT:2010-019255-22Summary Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted